• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Prescribing generic alternatives to brand-name combination medications can significantly reduce Medicare spending

byBrittany Hasty, MDandDaniel Fisher
August 27, 2018
in Chronic Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this retrospective cost analysis, Medicare spending exceeded $2.9 billion for the 10 most costly brand-name combination medications available from 2011 to 2016.

2. By switching to generic alternatives for these combination drugs, Medicare Part D beneficiaries would have been estimated to save $2.7 billion.

Evidence Rating: 2 (Good)

Study Rundown: Fixed-dose combination medications are often touted as being more convenient for patients, thus leading to better adherence. However, these combination medications are often brand-name and come at an increased cost compared to their generic counterparts. In this retrospective cost analysis, Medicare spending exceeded $2.9 billion the 10 most costly brand-name combination medications available from 2011 to 2016. It was further estimated that by switching to generic alternatives, Medicare Part D beneficiaries could have saved a total of $2.7 billion. In 2016 alone, by switching 29 brand-name combination drugs for their generic alternatives, the estimated savings would have been $925 million dollars.

The United States spends more on prescription medications than many developed nations, and this article presents one way in which physicians can subvert some of this cost. Though a limitation of this study is that certain select patients require the brand name medication over the generic alternatives, these are a very small minority and exclusion of these patients would be unlikely to change the relative financial disparity between brand-name and generic medications appreciably.

Click to read the study in JAMA

Relevant Reading: Health care spending in the United States and other high-income countries

RELATED REPORTS

Accelerated approval drugs incur significant fee-for-service Medicare costs

#VisualAbstract High cost of healthcare was the highest patient-reported barrier to accessing outpatient dermatologic care

United States providers increased prescribing of buprenorphine/naloxone

In-Depth [retrospective analysis]: Using the Medicare Part D data set, this study looked at Part D beneficiaries from 2011 to 2016 who were prescribed medications that accounted for the highest cost of spending in 2015. Drugs without identical or therapeutically equivalent generic alternatives were excluded. Of the 1500 medications identified, 29 brand-name combination drugs were selected for analysis to estimate the potential cost difference between brand-name combination drugs and their suitable alternatives. The 29 brand-name drugs were broken down into 3 categories: those that had generic medications in identical doses (n=20), those that has generic substitutes in different doses (n=3), and those with therapeutically suitable generic alternatives (n=6). By prescribing medications with identical generic alternatives instead of brand-name combination drugs, the cost savings was estimated to be $235 million. By using medications with generic substitutes at different doses, the estimated cost savings was $219 million. For medications with therapeutically suitable generic alternatives, the cost savings was an estimated $471 million. In 2016 alone, by using generic alternatives on these 29 drugs, the estimated cost savings would have been $925 million. Overall, Medicare spending exceeded $2.9 billion for the 10 most costly brand-name combination medications over the 5-year study period. By switching to generic alternatives for these combination drugs, Medicare Part D beneficiaries would have been estimated to save $2.7 billion.

Image: CC/Wiki

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: healthcare costsmedicare
Previous Post

Clinical report provides guidance on marijuana use in pregnancy and lactation

Next Post

2 Minute Medicine Rewind August 27, 2018

RelatedReports

Estrogen withdrawal associated with perimenopausal depression
Oncology

Accelerated approval drugs incur significant fee-for-service Medicare costs

June 22, 2022
#VisualAbstract High cost of healthcare was the highest patient-reported barrier to accessing outpatient dermatologic care
StudyGraphics

#VisualAbstract High cost of healthcare was the highest patient-reported barrier to accessing outpatient dermatologic care

November 27, 2021
Patients with low back pain or pain at multiple sites at highest risk for chronic opioid use
Wellness

United States providers increased prescribing of buprenorphine/naloxone

September 28, 2021
Psychological impact of COVID-19 on health care workers in Singapore
Psychiatry

Association of ECT with risks of all-cause mortality and suicide in older Medicare patients

September 15, 2021
Next Post
Certain cancer therapy innovations not associated with decreasing mortality

2 Minute Medicine Rewind August 27, 2018

High schoolers use e-cigarettes to vaporize cannabis

E-cigarette use common, especially among younger adults and those in the LBGTQ community

Psychiatric conditions less likely to be granted physician-assisted suicide

Improved cardiovascular health associated with lower incidence of dementia in older adults

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.